Developing a Nature Inspired Nanoparticle Drug Delivery System

DLVR Therapeutics Inc. is a privately held biotechnology company based in Toronto, Ontario, Canada.  Founded in 2011, the company is focused on developing a novel, HDL-mimicking nanoparticle delivery system suitable for a variety of different payloads with a particular suitability for oncology indications. The ultra-small DLVR technology – which is nontoxic, biocompatible, and biodegradable – has the potential to: effectively target and deliver siRNA to the cytosol of cells; increase the efficacy and safety of chemotherapeutics; and, enhance the delivery of photodynamic therapy and contrast imaging agents.